Louisvill Metabolic and Atherosclerosis Research Center (L-MARC) — Louisville, Kentucky

Louisvill Metabolic and Atherosclerosis Research Center (L-MARC) is a clinical research site located in Louisville, Kentucky, United States 40213.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Louisvill Metabolic and Atherosclerosis Research Center (L-MARC) has participated in 1 clinical trials.

Therapeutic areas: Nonalcoholic Steatohepatitis (NASH), Type 2 Diabetes.

Sponsors: HighTide Biopharma Pty Ltd.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Louisville

Browse all research sites in Kentucky · View every site in Louisville

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Louisvill Metabolic and Atherosclerosis Research Center (L-MARC)?

Louisvill Metabolic and Atherosclerosis Research Center (L-MARC) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Louisvill Metabolic and Atherosclerosis Research Center (L-MARC) conducted?

Louisvill Metabolic and Atherosclerosis Research Center (L-MARC) has 1 clinical trials on record. Their work covers Nonalcoholic Steatohepatitis (NASH), Type 2 Diabetes.

Is Louisvill Metabolic and Atherosclerosis Research Center (L-MARC) accredited by Crixeo Clinical Trials?

Louisvill Metabolic and Atherosclerosis Research Center (L-MARC) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Louisvill Metabolic and Atherosclerosis Research Center (L-MARC)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.